PD-L1 and PD-L2 expression levels are low in primary and secondary adenoid cystic carcinomas of the orbit: Therapeutic implications

Simple item page
dc.contributor.authorAfrogheh, Amir H.
dc.contributor.authorWolkow, Natalie
dc.contributor.authorJakobiec, Frederick Albert
dc.date.accessioned2021-01-20T07:23:50Z
dc.date.available2021-01-20T07:23:50Z
dc.date.issued2020
dc.description.abstractTo determine if there is a biologic rationale for using checkpoint inhibitor drugs targeting programmed cell death ligand 1 (PD-L1) and PD-L2 in the treatment of adenoid cystic carcinoma of the orbit. Methods: Twenty-three cases of adenoid cystic carcinoma involving the orbit (13 primary lacrimal gland, 5 secondarily extending into the orbit, and 5 unspecified) were examined histopathologically. Immunohistochemistry for PD-L1, PD-L2, and CD8 was performed. Charts were reviewed for clinical correlations. Results: Expression of PD-L1 and of PD-L2 was overall low in adenoid cystic carcinoma (mean expression 1.4 ± 0.9 of 5 for PD-L1, mean 0.83 ± 1.1 of 5 for PD-L2), and tumor-infiltrating CD8-positive T-lymphocytes were sparse (mean 1.1 ± 0.51 of 3). Only 13 of the 23 (57%) cases expressed PD-L1 as a combined positive score ≥1 of cells. No associations were found between expression levels of these markers and patient sex, tumor site of origin, Tumor, Node, Metastasis stage, or patient outcome.en_US
dc.identifier.citationAfrogheh, A. H. et al. (2020). PD-L1 and PD-L2 expression levels are low in primary and secondary adenoid cystic carcinomas of the orbit: Therapeutic implications. Ophthalmic Plastic and Reconstructive Surgery, 36(5), 444-450en_US
dc.identifier.issn1537-2677
dc.identifier.uri10.1097/IOP.0000000000001585
dc.identifier.urihttp://hdl.handle.net/10566/5691
dc.language.isoenen_US
dc.publisherWolters Kluwer Healthen_US
dc.subjectPD-L1en_US
dc.subjectPD-L2en_US
dc.subjectTherapeutic implicationsen_US
dc.subjectAdenoid cysticen_US
dc.subjectDrugsen_US
dc.titlePD-L1 and PD-L2 expression levels are low in primary and secondary adenoid cystic carcinomas of the orbit: Therapeutic implicationsen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
nihms-1612334.pdf
Size:
806.78 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research Articles